At this year’s CMEF exhibition in Shanghai, Avalue Technology unveiled a comprehensive lineup of smart healthcare solutions, highlighting its advanced AI computing platforms tailored for radiology, ultrasound, and endoscopy applications. All solutions are powered by the trusted Intel platform, delivering high performance and scalability to enhance diagnostic accuracy and processing efficiency in medical imaging and testing.
Avalue was honored to invite Leon Wei, Intel’s Healthcare Market Manager, and Jimmy Zhang, Director of Marketing for Edge Computing at Intel, to join the event and present Avalue’s Intel-based product lineup.
Leon emphasized Intel’s key strengths in medical AI platforms, particularly its superior computing power and optimized inference performance enabled by Intel’s Deep Learning Boost instruction set. These technologies accelerate deep learning inference with greater precision and enable edge deployment for applications such as portable ultrasound and real-time surgical imaging.
Jimmy further highlighted Intel’s end-to-end hardware ecosystem — from data center to the edge — and its strong alignment with medical hardware providers like Avalue. With modular solutions like Intel’s AI Reference Kits, Intel empowers end users to accelerate AI development and deployment while reducing integration complexity and time to market.
Linda Chen, Marketing Head of Avalue, noted, “Intel’s platform is widely preferred in the medical sector for its high-performance stability, broad software compatibility, long-term supply commitment, and excellent quality — all of which give our customers peace of mind when embracing smart healthcare innovations.”
This collaboration showcases the synergy between Avalue and Intel in advancing medical AI, combining hardware innovation with real-world deployment. Avalue remains committed to driving the future of intelligent healthcare through cutting-edge platform technologies.